So for me I'll use the $7 billion US market figure.
Assuming say 30% of that market is Abuse Deterrent three years from now based on a phasing in of ART/ADT rather than the FDA hitting the switch and mandating across the board.
So now it's $2.1 billion market opportunity three years from now.
Now let's assume Elite gets a 10% share of that market.
That's $210,000,000 in sales.
That is oh, about 50 times their current sales figure that supports a price of .32/share.
So, this is still looking mighty good to me!